APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ondansetron Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ondansetron Hydrochloride Injection Industry Growth and Trends Forecast to 2032

2 January 202690 pages

Choose your research edition.

Industry ResearchOndansetron Hydrochloride Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Ondansetron Hydrochloride Injection Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Ondansetron Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ondansetron Hydrochloride Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ondansetron Hydrochloride Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Ondansetron Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ondansetron Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ondansetron Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ondansetron Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ondansetron Hydrochloride Injection include Novartis, Mylan, Pfizer, Fresenius Kabi, Sagent, Heritage, AuroMedics, Athenex and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ondansetron Hydrochloride Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ondansetron Hydrochloride Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ondansetron Hydrochloride Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ondansetron Hydrochloride Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ondansetron Hydrochloride Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ondansetron Hydrochloride Injection Market by Company

Novartis

Mylan

Pfizer

Fresenius Kabi

Sagent

Heritage

AuroMedics

Athenex

Apotex

Ondansetron Hydrochloride Injection Segment by Type

2ml/vial

20ml/vial

Ondansetron Hydrochloride Injection Segment by Application

Special Clinic

Hospital

Recovery Center

Ondansetron Hydrochloride Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ondansetron Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ondansetron Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ondansetron Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ondansetron Hydrochloride Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ondansetron Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2ml/vial Table 2. Major Company of 20ml/vial Table 3. Global Ondansetron Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Ondansetron Hydrochloride Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ondansetron Hydrochloride Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Ondansetron Hydrochloride Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Ondansetron Hydrochloride Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Ondansetron Hydrochloride Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ondansetron Hydrochloride Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ondansetron Hydrochloride Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Ondansetron Hydrochloride Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Ondansetron Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Ondansetron Hydrochloride Injection Industry Trends Table 25. Ondansetron Hydrochloride Injection Industry Drivers Table 26. Ondansetron Hydrochloride Injection Industry Opportunities and Challenges Table 27. Ondansetron Hydrochloride Injection Industry Restraints Table 28. Global Ondansetron Hydrochloride Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ondansetron Hydrochloride Injection Revenue Market Share by Company (2021-2026) Table 30. Global Ondansetron Hydrochloride Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Ondansetron Hydrochloride Injection Sales Share by Company (2021-2026) Table 32. Global Ondansetron Hydrochloride Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Ondansetron Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ondansetron Hydrochloride Injection Major Company Production Sites and Headquarters Table 35. Global Ondansetron Hydrochloride Injection Company, Product Type & Application Table 36. Global Ondansetron Hydrochloride Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ondansetron Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ondansetron Hydrochloride Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ondansetron Hydrochloride Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Ondansetron Hydrochloride Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ondansetron Hydrochloride Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ondansetron Hydrochloride Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Ondansetron Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Ondansetron Hydrochloride Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Ondansetron Hydrochloride Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ondansetron Hydrochloride Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ondansetron Hydrochloride Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Ondansetron Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Ondansetron Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Ondansetron Hydrochloride Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ondansetron Hydrochloride Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Ondansetron Hydrochloride Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ondansetron Hydrochloride Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Ondansetron Hydrochloride Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ondansetron Hydrochloride Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ondansetron Hydrochloride Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Ondansetron Hydrochloride Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Ondansetron Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Ondansetron Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Novartis Ondansetron Hydrochloride Injection Product Portfolio Table 75. Novartis Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Ondansetron Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mylan Ondansetron Hydrochloride Injection Product Portfolio Table 80. Mylan Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Ondansetron Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Ondansetron Hydrochloride Injection Product Portfolio Table 85. Pfizer Recent Development Table 86. Fresenius Kabi Company Information Table 87. Fresenius Kabi Business Overview Table 88. Fresenius Kabi Ondansetron Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Fresenius Kabi Ondansetron Hydrochloride Injection Product Portfolio Table 90. Fresenius Kabi Recent Development Table 91. Sagent Company Information Table 92. Sagent Business Overview Table 93. Sagent Ondansetron Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sagent Ondansetron Hydrochloride Injection Product Portfolio Table 95. Sagent Recent Development Table 96. Heritage Company Information Table 97. Heritage Business Overview Table 98. Heritage Ondansetron Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Heritage Ondansetron Hydrochloride Injection Product Portfolio Table 100. Heritage Recent Development Table 101. AuroMedics Company Information Table 102. AuroMedics Business Overview Table 103. AuroMedics Ondansetron Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. AuroMedics Ondansetron Hydrochloride Injection Product Portfolio Table 105. AuroMedics Recent Development Table 106. Athenex Company Information Table 107. Athenex Business Overview Table 108. Athenex Ondansetron Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Athenex Ondansetron Hydrochloride Injection Product Portfolio Table 110. Athenex Recent Development Table 111. Apotex Company Information Table 112. Apotex Business Overview Table 113. Apotex Ondansetron Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Apotex Ondansetron Hydrochloride Injection Product Portfolio Table 115. Apotex Recent Development Table 116. North America Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Ondansetron Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 118. North America Ondansetron Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 119. North America Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Ondansetron Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 121. North America Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Ondansetron Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Ondansetron Hydrochloride Injection Market Share by Country (2021-2026) Table 124. North America Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Ondansetron Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 126. Europe Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Ondansetron Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 128. Europe Ondansetron Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 129. Europe Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Ondansetron Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Ondansetron Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Ondansetron Hydrochloride Injection Market Share by Country (2021-2026) Table 134. Europe Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Ondansetron Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Ondansetron Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Ondansetron Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Ondansetron Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Ondansetron Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Ondansetron Hydrochloride Injection Market Share by Country (2021-2026) Table 144. Asia-Pacific Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Ondansetron Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 146. Latin America Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Ondansetron Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 148. Latin America Ondansetron Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 149. Latin America Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Ondansetron Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Ondansetron Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Ondansetron Hydrochloride Injection Market Share by Country (2021-2026) Table 154. Latin America Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Ondansetron Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Ondansetron Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Ondansetron Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Ondansetron Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Ondansetron Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Ondansetron Hydrochloride Injection Market Share by Country (2021-2026) Table 164. Middle East and Africa Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Ondansetron Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Ondansetron Hydrochloride Injection Distributors List Table 169. Ondansetron Hydrochloride Injection Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Ondansetron Hydrochloride Injection Image Figure 2. Global Ondansetron Hydrochloride Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ondansetron Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ondansetron Hydrochloride Injection Sales (2021-2032) & (K Units) Figure 5. 2ml/vial Image Figure 6. Global 2ml/vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 20ml/vial Image Figure 8. Global 20ml/vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Ondansetron Hydrochloride Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ondansetron Hydrochloride Injection Market Share by Type 2025 VS 2032 Figure 11. North America Ondansetron Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Ondansetron Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Ondansetron Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ondansetron Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ondansetron Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ondansetron Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ondansetron Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ondansetron Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ondansetron Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ondansetron Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ondansetron Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Special Clinic Image Figure 24. Global Special Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Recovery Center Image Figure 28. Global Recovery Center Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Ondansetron Hydrochloride Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Ondansetron Hydrochloride Injection Market Share by Application 2025 VS 2032 Figure 31. North America Ondansetron Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Ondansetron Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Ondansetron Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Ondansetron Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Ondansetron Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Ondansetron Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Ondansetron Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Ondansetron Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Ondansetron Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Ondansetron Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Ondansetron Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Ondansetron Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Ondansetron Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Ondansetron Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ondansetron Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Ondansetron Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ondansetron Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ondansetron Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ondansetron Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Ondansetron Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ondansetron Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Ondansetron Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ondansetron Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Ondansetron Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ondansetron Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ondansetron Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ondansetron Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Ondansetron Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ondansetron Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Ondansetron Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Ondansetron Hydrochloride Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Ondansetron Hydrochloride Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 2ml/vial
  • 20ml/vial
Applications
  • Special Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Novartis
  • Mylan
  • Pfizer
  • Fresenius Kabi
  • Sagent
  • Heritage
  • AuroMedics
  • Athenex
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ondansetron Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ondansetron Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ondansetron Hydrochloride Injection Market by Type
  6. 1.3.1 2ml/vial
  7. 1.3.2 20ml/vial
  8. 1.4 Global Ondansetron Hydrochloride Injection Market Size by Type
  9. 1.4.1 Global Ondansetron Hydrochloride Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ondansetron Hydrochloride Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ondansetron Hydrochloride Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ondansetron Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ondansetron Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ondansetron Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ondansetron Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ondansetron Hydrochloride Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ondansetron Hydrochloride Injection Industry Trends
  2. 2.2 Ondansetron Hydrochloride Injection Industry Drivers
  3. 2.3 Ondansetron Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Ondansetron Hydrochloride Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ondansetron Hydrochloride Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Ondansetron Hydrochloride Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Ondansetron Hydrochloride Injection Price (2021-2026)
  4. 3.4 Global Ondansetron Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ondansetron Hydrochloride Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Ondansetron Hydrochloride Injection Company, Product Type & Application
  7. 3.7 Global Ondansetron Hydrochloride Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ondansetron Hydrochloride Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ondansetron Hydrochloride Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ondansetron Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Ondansetron Hydrochloride Injection Regional Status and Outlook
  1. 4.1 Global Ondansetron Hydrochloride Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ondansetron Hydrochloride Injection Historic Market Size by Region
  3. 4.2.1 Global Ondansetron Hydrochloride Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ondansetron Hydrochloride Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ondansetron Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ondansetron Hydrochloride Injection Forecasted Market Size by Region
  7. 4.3.1 Global Ondansetron Hydrochloride Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ondansetron Hydrochloride Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ondansetron Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ondansetron Hydrochloride Injection by Application
  1. 5.1 Ondansetron Hydrochloride Injection Market by Application
  2. 5.1.1 Special Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Ondansetron Hydrochloride Injection Market Size by Application
  6. 5.2.1 Global Ondansetron Hydrochloride Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ondansetron Hydrochloride Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ondansetron Hydrochloride Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ondansetron Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ondansetron Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ondansetron Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ondansetron Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ondansetron Hydrochloride Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Ondansetron Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Ondansetron Hydrochloride Injection Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Ondansetron Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Ondansetron Hydrochloride Injection Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Ondansetron Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Ondansetron Hydrochloride Injection Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Ondansetron Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fresenius Kabi Ondansetron Hydrochloride Injection Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Sagent
  26. 6.5.1 Sagent Company Information
  27. 6.5.2 Sagent Business Overview
  28. 6.5.3 Sagent Ondansetron Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sagent Ondansetron Hydrochloride Injection Product Portfolio
  30. 6.5.5 Sagent Recent Developments
  31. 6.6 Heritage
  32. 6.6.1 Heritage Company Information
  33. 6.6.2 Heritage Business Overview
  34. 6.6.3 Heritage Ondansetron Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Heritage Ondansetron Hydrochloride Injection Product Portfolio
  36. 6.6.5 Heritage Recent Developments
  37. 6.7 AuroMedics
  38. 6.7.1 AuroMedics Company Information
  39. 6.7.2 AuroMedics Business Overview
  40. 6.7.3 AuroMedics Ondansetron Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AuroMedics Ondansetron Hydrochloride Injection Product Portfolio
  42. 6.7.5 AuroMedics Recent Developments
  43. 6.8 Athenex
  44. 6.8.1 Athenex Company Information
  45. 6.8.2 Athenex Business Overview
  46. 6.8.3 Athenex Ondansetron Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Athenex Ondansetron Hydrochloride Injection Product Portfolio
  48. 6.8.5 Athenex Recent Developments
  49. 6.9 Apotex
  50. 6.9.1 Apotex Company Information
  51. 6.9.2 Apotex Business Overview
  52. 6.9.3 Apotex Ondansetron Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Apotex Ondansetron Hydrochloride Injection Product Portfolio
  54. 6.9.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Ondansetron Hydrochloride Injection Sales by Country
  2. 7.1.1 North America Ondansetron Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ondansetron Hydrochloride Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ondansetron Hydrochloride Injection Market Size by Country
  6. 7.2.1 North America Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ondansetron Hydrochloride Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ondansetron Hydrochloride Injection Sales by Country
  2. 8.1.1 Europe Ondansetron Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ondansetron Hydrochloride Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ondansetron Hydrochloride Injection Market Size by Country
  6. 8.2.1 Europe Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ondansetron Hydrochloride Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ondansetron Hydrochloride Injection Sales by Country
  2. 9.1.1 Asia-Pacific Ondansetron Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ondansetron Hydrochloride Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ondansetron Hydrochloride Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ondansetron Hydrochloride Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ondansetron Hydrochloride Injection Sales by Country
  2. 10.1.1 South America Ondansetron Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ondansetron Hydrochloride Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ondansetron Hydrochloride Injection Market Size by Country
  6. 10.2.1 South America Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ondansetron Hydrochloride Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ondansetron Hydrochloride Injection Sales by Country
  2. 11.1.1 Middle East and Africa Ondansetron Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ondansetron Hydrochloride Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ondansetron Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ondansetron Hydrochloride Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Ondansetron Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ondansetron Hydrochloride Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ondansetron Hydrochloride Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ondansetron Hydrochloride Injection Value Chain Analysis
  2. 12.1.1 Ondansetron Hydrochloride Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ondansetron Hydrochloride Injection Production Mode & Process
  7. 12.2 Ondansetron Hydrochloride Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ondansetron Hydrochloride Injection Distributors
  10. 12.2.3 Ondansetron Hydrochloride Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst